Takeda's Vedolizumab Demonstrated Robust Clinical Effectiveness and Safety in Inflammatory Bowel Disease in More Than 50 Real-World Studies
Allergan Enters Into Licensing Agreement with AstraZeneca to Obtain Worldwide Rights to Inflammatory Disorder Development Program
